Occupier

Find Out The Latest

Keep in touch with news and developments from The Oxford Science Park and its occupiers here.

You can also follow us on LinkedIn

Scancell signs Commercial License Agreement with Genmab

25 Oct 2022

Scancell Holdings plc ("Scancell" or the "Company") Scancell signs Commercial License Agreement with Genmab Genmab granted worldwide license to anti-glycan monoclonal antibody generated via Scancell's proprietary GlyMab® platform, for the development and commercialisation of novel therapeutic products Scancell to receive from Genmab an upfront payment as well as potential milestone payments of up to $208 million for each product... Read more

Oxford Cancer Biomarkers announces European expansion of chemotherapy toxicity test & independent real-world evidence of patient benefit

26 Sep 2022

ToxNav®, a CE-marked in vitro diagnostics product is now registered in the European database on medical devices (EUDAMED). Independent study publication highlights patient benefits, cost-savings and opportunity for ToxNav® to address potential health inequalities in current approaches to DPYD testing. OXFORD, UK – 26th September 2022 – Oxford Cancer Biomarkers Ltd (OCB) announces that ToxNav®, its proprietary pharmacogenomics test for... Read more

Evox Therapeutics expands its exosome manufacturing patent portfolio

07 Sep 2022

EVOX THERAPEUTICS EXPANDS ITS EXOSOME MANUFACTURING PATENT PORTFOLIO Four newly issued patents cover key purification processes and methods of exogenous loading OXFORD, United Kingdom, Sept. 07, 2022 (GLOBE NEWSWIRE) -- Evox Therapeutics Ltd (‘Evox’ or the ‘Company’), a leading exosome therapeutics company, today announced that the Company has been granted four new patents covering a broad range of exosome manufacturing methods and... Read more

Digital Catapult unveils five firms to explore potential of Open RAN technology on SONIC Labs testbed

18 Jul 2022

Digital Catapult, with support from its partner Ofcom, has onboarded five companies to its SONIC Labs programme to trial the integration of Open RAN (Radio Access Network) products into working end-to-end systems Participating organisations will work collaboratively with each other, Digital Catapult and Ofcom to integrate and test their products in lab and indoor mobile network settings, accelerating their route to... Read more

Oxford Science Enterprises Raises £250 Million